Use Case Articles

Biomarkers 2023 was held in Manchester, UK on the 27th and 28th of February. The event brought together a diverse group of experts, across pharma, biotech, and academic institutions.

In all areas of biomedicine, it is crucial for researchers to stay up to date and informed of developments in their respective field of study. Nowhere is this more important than in the field of cancer research, which consistently tops the annual charts of research-spend and subsequent volumes of research-output.

Chronic Obstructive Pulmonary Disease (COPD) describes a group of conditions which cause breathing difficulties, and includes chronic bronchitis and emphysema. The condition mainly affects older people who smoke and is typically managed by clinicians and other health professionals in a primary care setting.

Clinical Decision Support tools are a crucial part of modern healthcare provision. Patient outcomes are improved when medical staff are able to make clinical decisions based on the best evidence, and point of care tools are now ubiquitous across a wide range of clinical settings.

Spinal muscular atrophy (SMA) is a rare autosomal recessive disease, characterized by progressive degeneration of muscular motor neurons. SMA has a prevalence of 1-2 per 100,000 persons and an incidence of 1 in 10,000 live births. Heterogeneity of symptoms in SMA, making the diagnosis and treatment challenging to the clinicians.